Easy To Use Patents Search & Patent Lawyer Directory

At Patents you can conduct a Patent Search, File a Patent Application, find a Patent Attorney, or search available technology through our Patent Exchange. Patents are available using simple keyword or date criteria. If you are looking to hire a patent attorney, you've come to the right place. Protect your idea and hire a patent lawyer.

Searching:





Search by keyword, patent number, inventor, assignee, city or state:




Patent # Description
2016/0303237 PHOTODYNAMIC THERAPY FOR TREATING CLOSTRIDIUM DIFFICILE INFECTION USING CHITOSAN AND TETRACYCLINE
Effective Photodynamic therapy (PDT) against C. difficile is provided using a composition including chitosan and tetracycline.
2016/0303236 REGIONALLY ACTIVATED DRUG DELIVERY NANOPARTICLES
Methods, systems, and devices are disclosed for systemic delivery and selective and localized activation of nanoparticles containing an agent in an inactive...
2016/0303235 Stable Aqueous Formulations of Adalimumab
The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these...
2016/0303234 Stable Aqueous Formulations of Adalimumab
The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these...
2016/0303233 Stable Aqueous Formulations of Adalimumab
The invention provides aqueous pharmaceutical adalimumab compositions suitable for long-term storage of adalimumab, methods of manufacture of these...
2016/0303232 COMBINATION TREATMENTS WITH SERIBANTUMAB
Compositions and methods for treating a cancer in a selected human patient are provided, comprising administering to the patient a combination of an anti-ErbB3...
2016/0303231 TREATING CANCER WITH A COMBINATION OF A PD-1 ANTAGONIST AND A VEGFR INHIBITOR
The present disclosure describes combination therapies comprising an antagonist of Programmed Death 1 receptor (PD-1) and VEGFR inhibitor, and the use of the...
2016/0303230 CHIMERIC ANTIGEN RECEPTOR FOR BISPECIFIC ACTIVATION AND TARGETING OF T LYMPHOCYTES
Embodiments of the invention include methods and compositions related to improved cells encoding a chimeric antigen receptor that is specific for two or more...
2016/0303229 METHODS OF TREATING NECROTIZING ENTEROCOLITIS BY ADMINISTERING NUCLEAR OLIGOMERIZATION DOMAIN-2 AGONISTS,TLR9...
The present invention relates to the use of a TLR9 agonist and/or a TLR4 antagonist and/or a NOD2 agonist for treatment or prevention of disorders involving...
2016/0303228 SILICON DIOXIDE NANOPARTICLES AND THE USE THEREOF FOR VACCINATION
The invention relates to ultrasmall, monodisperse nanoparticles comprising silicon dioxide to the surface of which at least one antigen is attached. The...
2016/0303227 ANTI-GANGLIOSIDE COMPOUND FOR TARGETING CANCER AND GENERATING ANTIBODIES
It is provided a multivalent gangloside carbohydrate as a therapeutic cancer vaccine. The GD2 and GD3 carbohydrate conjugated disclosed are linked by a spacer...
2016/0303226 HEAT-TREATED FORMULATION OF BIFIDOBACTERIUM LACTIS NCC 2818 REDUCES ALLERGIC MANIFESTATIONS
Heat treated Bifidobacterium lactis NCC 2818 reduces the symptoms of allergies in different groups of patients, such as allergies originating from food...
2016/0303225 HUMAN HERPESVIRUS TRIMERIC GLYCOPROTEIN B, PROTEIN COMPLEXES COMPRISING TRIMERIC gB AND THEIR USE AS VACCINES
The present disclosure provides modified human herpesvirus glycoprotein B (gB) proteins that incorporate unique mechanisms for generating proteins that mimic...
2016/0303224 EPSTEIN-BARR VIRUS VACCINES
Vaccines are provided that elicit neutralizing antibodies to Epstein-Barr virus (EBV). Some vaccines comprise nanoparticles that display envelope proteins from...
2016/0303223 UNIVERSAL VIRUS-LIKE PARTICLE (VLP) INFLUENZA VACCINES
Described herein are influenza virus-like particles (VLPs) that display on truncated, re-engineered or remodeled HA molecules on their surface. Also described...
2016/0303222 Compositions and Methods for Vaccination Against Influenza a Virus
Disclosed herein are compositions and methods useful for immunizing a subject against disease caused by influenza A. Disclosed methods comprise administering...
2016/0303221 VIRUS LIKE PARTICLE COMPOSITIONS AND METHODS OF USE
The invention features compositions and methods for the prevention or treatment of one or more strains of Chikungunya virus, as well as other ...
2016/0303220 Immortalized Porcine Alveolar Macrophage
The present invention relates to immortalized porcine alveolar macrophages (PAMs), to cell cultures comprising such PAMs, to methods for the immortalization of...
2016/0303219 Swine Vaccine Against PRRS and Lawsonia Intracellularis
The present invention pertains to a swine vaccine, in particular a vaccine comprising in combination live attenuated PRRS virus and inactivated Lawsonia...
2016/0303218 VACCINE AGAINST LAWSONIA INTRACELLULARIS AND PORCINE CIRCOVIRUS 2
The present invention pertains to a vaccine comprising in combination killed whole cell Lawsonia intracellularis bacteria and porcine circo virus 2 (PCV2) ORF2...
2016/0303217 Immunogenic Compositions and Vaccines Derived From Bacterial Surface Receptor Proteins
The disclosure provides immunogenic compositions comprising a polypeptide comprising a C-lobe domain or an N-lobe domain of a HIBP surface receptor protein...
2016/0303216 BORDETELLA PERTUSSIS IMMUNOGENIC VACCINE COMPOSITIONS
This invention is directed to composition, vaccines, tools and methods in the treatment and prevention of Bordetella pertussis. In particular, the invention is...
2016/0303215 INTEGRATION OF MENINGOCOCCAL CONJUGATE VACCINATION
The invention provides a method for immunising a patient, comprising administering multiple conjugates meningococcal capsular saccharides, wherein each...
2016/0303214 PROCESS FOR DETERGENT-FREE PRODUCTION OF OUTER MEMBRANE VESICLES OF A GRAM-NEGATIVE BACTERIUM
The present invention relates to the fields of medical microbiology and vaccines. In particular the invention relates to a process for detergent-free...
2016/0303213 PREVENTION OF STAPHYLOCOCCUS AUREUS INFECTIONS BY GLYCOPROTEIN VACCINES SYNTHESIZED IN ESCHERICHIA COLI
Provided herein are immunogenic compositions and vaccines for the treatment and prevention of Staphylococcus aureus infections. These immunogenic compositions...
2016/0303212 Interferon- Production Modulating Listeria Strains and Methods for Using Same
Mutant Listeria bacteria that modulate interferon-.beta. production are provided. The subject bacteria are characterized by having a mutation in a gene chosen...
2016/0303211 DNA VACCINE CONTAINING SPECIFIC EPITOPE OF APOLIPOPROTEIN (a)
The present invention provides an agent for the treatment or prophylaxis of arteriosclerosis comprising an expression vector encoding a chimeric Hepatitis B...
2016/0303210 COMPOSITION FOR TREATING PROSTATE CANCER (PCa)
The present invention relates to an active (immunostimulatory) composition comprising at least one RNA, preferably an mRNA, encoding at least two (preferably...
2016/0303209 Autoimmune Antigens and Cancer
Autoimmune diseases are thought to be initiated by exposures to foreign antigens that cross-react with endogenous molecules. Analyses of peripheral blood...
2016/0303208 METHOD FOR TREATING AMYLOID DISEASE
The invention relates to methods for treating human amyloid disease by administration of modified A.beta. peptide immunogens.
2016/0303207 BETA-LACTAMASES WITH IMPROVED PROPERTIES FOR THERAPY
This invention relates to, in part, compositions of beta-lactamases and methods of using these enzymes in, for example, gastrointestinal tract (GI tract)...
2016/0303206 PHARMACEUTICAL OR NUTRITIONAL COMPOSITIONS CONTAINING GALACTOSIDASE, AND THEIR USE
The present disclosure relates to pharmaceutical or nutritional compositions containing .alpha.-galactosidase and .beta.-galactosidase and their use in the...
2016/0303205 Combination Therapies for Lysosomal Storage Diseases
Disclosed are methods of treating lysosomal storage diseases, including Globoid Cell Leukodystrophy (GSD). GSD is refractory to standard treatments, where even...
2016/0303204 METHOD FOR TREATING SYSTEMIC DNA MUTATION DISEASE
The invention is directed to treatment of systemic DNA mutation diseases accompanied with development of somatic mosaicism and elevation of blood extracellular...
2016/0303203 COMPOSITIONS AND METHODS FOR THE TREATMENT OF WOUNDS
The present invention is directed to a wound composition comprising an effective amount of phenytoin and/or an effective amount of vitamin C, and an effective...
2016/0303202 LIQUID FORMULATION OF FSH
The present invention relates to a liquid pharmaceutical composition comprising a follicle stimulating hormone polypeptide and benzalkonium chloride and benzyl...
2016/0303201 LIQUID FORMULATION OF FSH
The present invention relates to a liquid pharmaceutical composition comprising a follicle stimulating hormone polypeptide and benzalkonium chloride and benzyl...
2016/0303200 PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF METASTATIC CANCER
The invention provides isolated peptides, fragments and derivatives thereof and pharmaceutical compositions comprising same that are useful for the prevention...
2016/0303199 USE OF URODILATIN FOR PREPARING A MEDICAMENT FOR THE TREATMENT OF CARDIOVASCULAR, RENAL, PULMONARY AND NEURONAL...
Use of urodilatin for preparing a medicament for the treatment of cardiovascular, renal, pulmonary and neuronal syndromes while avoiding a rebound, wherein...
2016/0303198 METHOD OF IMMUNOTHERAPY FOR TREATMENT OF HUMAN PAPILLOMAVIRUS INFECTION
A method of treating human papillomavirus (HPV), by administering a therapeutically effective amount of a primary cell-derived biologic to a patient infected...
2016/0303197 METHODS FOR REPAIRING TISSUE DAMAGE USING PROTEASE-RESISTANT MUTANTS OF STROMAL CELL DERIVED FACTOR-1
The present invention features methods for treating or ameliorating tissue damage using intravenous administration of compositions (for example, isolated...
2016/0303196 USE OF CCL1 IN THERAPY
A method of treating a medical condition in which suppression of effector T cells is beneficial in a subject in need thereof is disclosed. The method...
2016/0303195 METHODS FOR TREATING INFLAMMATORY DISORDERS AND TRAUMATIC BRAIN INJURY USING STABILIZED NON-HEMATOPOIETIC EPO...
The described invention provides methods for treating an inflammatory brain disease, disorder or condition and for treating a traumatic brain injury having an...
2016/0303194 Compositions And Method For Treatment Of Inflammatory Bowel Disease
A method is provided for treating bowel disease related to the activity of TNF-.alpha., through the administration of a .theta.-defensin, analog, or...
2016/0303193 INHIBITION OF COLLAGEN SYNTHESIS
Therapies and compositions for reducing collagen synthesis in mammalian cells and tissues wherein the targets are scleraxis, scleraxis-binding sites,...
2016/0303192 OPTICALLY-CONTROLLED CNS DYSFUNCTION
Provided herein are animals expressing light-responsive opsin proteins in the basal lateral amygdala of the brain and methods for producing the same wherein...
2016/0303191 COMPOSITION FOR PREVENTING OR TREATING OSTEOARTHRITIS
An object of the present invention is to provide a means for preventing or treating osteoarthritis. The present invention provides a composition for preventing...
2016/0303190 METHOD FOR TREATMENT OF GASTRIC ULCERS
The preset invention relates to a new method or composition for treating a gastric ulcer, preventing or treating an infection of H. pylori, particularly...
2016/0303189 Applications of Recombined Ganoderma Lucidum Immunoregulation Protein in Preparing Drugs for Treating Tissue...
Applications of recombined ganoderma lucidum immunoregulation protein (rLZ-8) in preparing drugs for treating tissue fibrosis are provided.
2016/0303188 METHOD FOR FORMING AN IMMUNE-TOLERANT SITE AND METHOD FOR ATTRACTING IMMUNOSUPPRESSIVE CELLS
A method for forming an immune-tolerant site, and a method for attracting immunosuppressive cells, comprising contacting an agent comprising SEK-1005 (Ser, ...
← Previous | 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 | Next →

File A Patent Application

  • Protect your idea -- Don't let someone else file first. Learn more.

  • 3 Easy Steps -- Complete Form, application Review, and File. See our process.

  • Attorney Review -- Have your application reviewed by a Patent Attorney. See what's included.